Andrew Huberman's Peptide Recommendations 2026

TLDR: Andrew Huberman, the Stanford neuroscientist behind the Huberman Lab podcast, has discussed over a dozen peptides across his episodes, but he's only personally used a handful. His top picks based on personal experience include BPC-157 (which resolved his chronic back pain in just two injections), Pinealon (which doubled his REM sleep), and Semax (for cognitive focus). For growth hormone support, he favors Ipamorelin at 100 mcg as the "cleanest" option. Huberman strongly advises getting peptides through board-certified physicians and compounding pharmacies rather than gray market sources, and he stresses the cancer risks of peptides that upregulate VEGF or growth hormone pathways.

Disclaimer: This content is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before using any peptides. Many peptides discussed here are not FDA-approved for the uses described and are classified as research compounds.

Why Does Andrew Huberman Talk About Peptides?

Huberman's interest in peptides stems from his background in neurobiology and his willingness to self-experiment. Unlike many academics who stay theoretical, Huberman openly shares what he's tried, what worked, and what didn't.

His main peptide episode, "Benefits & Risks of Peptide Therapeutics for Physical & Mental Health," aired in April 2024 and remains the most detailed breakdown of peptide science from a mainstream science communicator. He followed this with a deep-dive featuring peptide physician Dr. Craig Koniver in October 2024, which covered clinical protocols and stacking strategies.

Huberman's approach stands out because he emphasizes both the potential benefits and the legitimate risks. He's not selling anything, and he's repeatedly warned listeners about the dangers of gray market sourcing and the real possibility of tumor promotion from certain compounds.

Which Peptides Has Huberman Actually Taken?

Based on his public statements across podcast episodes and interviews, Huberman has personally experimented with five peptides:

BPC-157 (Body Protection Compound-157)

This is Huberman's most dramatic personal success story. He developed L5 disc compression from deadlifting that caused persistent lower back pain. After trying massage, heat therapy, and electrical stimulation without relief, he used BPC-157.

"Within two injections of BPC-157, my persistent back pain was completely resolved," Huberman stated on his April 2024 episode.

His protocol: 300-500 micrograms subcutaneously, injected near the injury site, two to three times weekly for about eight weeks, followed by an eight to ten week break.

The catch: BPC-157 was placed on the FDA's Category 2 restricted list in October 2023. As of May 2026, it remains technically banned for compounding, though HHS Secretary RFK Jr. announced in February 2026 that approximately 14 restricted peptides are expected to return to Category 1 status.

Current alternative: Pentadeca Arginate (PDA) shares the same 15-amino-acid sequence with an arginine salt instead of acetate. Dr. Craig Koniver reports results "very close to BPC" at 250-500 mcg daily.

Pinealon (REM Sleep Enhancement)

This is the peptide Huberman found most surprising. Over four to six months of intermittent use, Pinealon doubled his REM sleep from roughly 1-1.5 hours to nearly 3 hours per night, tracked objectively with sleep monitoring devices.

"I've tried a lot of peptides. I rarely keep doing them for long," Huberman noted. "Pinealon has very little human data, but I got great results from it."

His protocol: Injectable Pinealon combined with oral glycine (3,000-5,000 mg), used intermittently rather than nightly.

Pinealon is one of the smallest peptides available and is believed to regenerate pinealocytes, the cells in the pineal gland that produce melatonin.

Sermorelin (Growth Hormone Secretagogue)

Huberman used Sermorelin for one to two nights weekly over a period of a couple years. The results were mixed.

"Sermorelin gave me great sleep, but only in the first part of the night," he explained. "It nuked my rapid eye movement sleep in the second half of the night and spiked my prostate-specific antigen."

He has since stopped taking Sermorelin almost completely due to these side effects. This honest assessment of a negative experience is typical of Huberman's transparent approach.

MK-677 (Oral Growth Hormone Secretagogue)

Huberman tried MK-677 only once and described the experience negatively. The oral peptide "destroyed sleep through extreme hunger," making it impractical for regular use in his view. MK-677 was subsequently removed from the FDA's compounding approval list.

Semax (Cognitive Enhancement)

Huberman has mentioned Semax as a "go-to" peptide for focus and memory. Semax is a synthetic heptapeptide derived from ACTH (adrenocorticotropic hormone) developed in Russia in the 1980s. It's registered as a pharmaceutical in Russia for stroke recovery, cognitive impairment, and ADHD, but remains a research compound in the United States.

What Does Huberman Recommend for Tissue Repair and Healing?

For injury recovery, Huberman recommends two primary peptides, often used together:

BPC-157

Huberman explains that BPC-157 promotes angiogenesis (formation of new blood vessels), which aids tissue repair by increasing blood flow to the injury site. It encourages fibroblast migration and vascular growth, enhancing healing of ligaments, tendons, and nerves.

Risk highlighted: BPC-157 increases VEGF (vascular endothelial growth factor), which can theoretically promote tumor growth by enhancing blood flow to cancerous cells. "If you have a tumor or are predisposed to cancer, this is a real concern," Huberman warned.

TB-500 (Thymosin Beta-4)

TB-500 is a shorter synthesized version of thymosin beta-4, a molecule from the thymus gland. While BPC-157 primarily promotes blood vessel formation, TB-500 enhances cell migration and differentiation.

"Anecdotally, people are taking TB-500 alone or with BPC-157 and reporting more thorough or more rapid tissue rejuvenation," Huberman noted. He has discussed this peptide but has not confirmed personal use.

The combination of BPC-157 and TB-500 is commonly called the "Wolverine Stack" in peptide communities for its purported accelerated healing effects.

What Are Huberman's Views on Growth Hormone Peptides?

Huberman and Dr. Koniver discussed growth hormone secretagogues extensively. These peptides stimulate your pituitary gland to release growth hormone naturally, rather than replacing it with exogenous hormone.

Ipamorelin (Huberman's Top Pick)

Huberman considers Ipamorelin the "cleanest" growth hormone secretagogue because it binds only the growth hormone receptor without affecting prolactin, ACTH, or appetite.

Recommended dose: 100 micrograms maximum. Higher doses risk anaphylaxis, according to the Koniver episode.

Protocol: Take at bedtime on an empty stomach (no carbs 45 minutes prior), five days on, two days off.

Tesamorelin

FDA-approved for HIV-associated lipodystrophy under the brand name Egrifta, Tesamorelin is used off-label for visceral fat reduction. Huberman noted it appears more effective in females than males.

Dose discussed: 2 milligrams per injection.

Hexarelin

Positioned as an energy and endurance enhancer without the appetite stimulation of other GH peptides, Hexarelin comes with a warning. Huberman noted it can cause permanent receptor desensitization with overuse, making it unsuitable for long-term protocols.

CJC-1295

A longer-acting GHRH peptide typically dosed once or twice weekly. Huberman mentioned CJC-1295 was associated with cardiovascular death in clinical trials, which contributed to its placement on the FDA's restricted list. As of March 2026, CJC-1295 has been reapproved for prescription use.

What Does Huberman Say About GLP-1 Weight Loss Peptides?

Huberman has discussed GLP-1 agonists (semaglutide, tirzepatide, retatrutide) across multiple episodes but has clearly stated he has never used them.

"For the record, I've not tried GLP-1 agonists," he clarified on X (formerly Twitter).

His coverage has been educational rather than testimonial. In his episode with Dr. Zachary Knight (June 2024), Huberman explored how these medications reduce appetite through brain signaling pathways, not just slowing digestion.

On Retatrutide

Huberman expressed enthusiasm about retatrutide, which adds glucagon receptor activation to the GLP-1 and GIP targets of tirzepatide.

"In a phase three clinical trial in humans, it caused up to one-third loss of body weight in about six months' time," Huberman reported. "And it seems like there's some degree of muscle sparing."

Muscle Preservation Strategy

When discussing GLP-1 use with Dr. Koniver, the recommendation was micro-dosing combined with adequate protein intake and resistance training. Some practitioners stack GLP-1s with Sermorelin to offset potential muscle loss.

What Are Huberman's Safety Warnings About Peptides?

Huberman dedicates significant time to peptide risks, a contrast to promotional content from sellers. His main warnings include:

Cancer risk from VEGF/GH upregulation: "Avoid peptides, especially for growth hormone, if you have a tumor or cancer," Huberman stated. The concern applies to BPC-157, TB-500, and all GH secretagogues.

Lipopolysaccharide (LPS) contamination: Unregulated "research peptides" often contain bacterial endotoxins that accumulate over time and can trigger anaphylactic reactions. "Reported cases of severe reactions from research peptides exist," he warned.

Pleiotropic effects: "There's no way to avoid the pleiotropic nature of peptides. They act broadly. You will activate additional pathways regardless of the intended target."

Side effects by class:

• Melanocortin peptides (PT-141, Melanotan): Nausea, blood pressure spikes, melanoma risk
• Growth hormone peptides: Carpal tunnel, facial structure changes, indiscriminate tissue growth
• Sermorelin: Can elevate PSA levels (prostate marker)
• Hexarelin: Prolactin elevation, permanent receptor desensitization

How Does Huberman Recommend Sourcing Peptides?

Huberman's sourcing hierarchy is clear:

1. Prescription from a board-certified physician through a licensed compounding pharmacy
2. FDA-approved brand drugs where available (Egrifta, Vyleesi)
3. Never from gray market or "research only" labeled suppliers

"Use prescription peptides from board-certified physicians," Huberman emphasized. "Ensure lipopolysaccharide removal from manufacturing. Avoid gray or black market sources."

Dr. Koniver added that compounding pharmacies undergo FDA inspection and test for endotoxins, something research chemical suppliers do not guarantee.

What's the Current Legal Status of Peptides in 2026?

The regulatory situation shifted dramatically in late 2023 when the FDA placed 19 peptides on its Category 2 "Substances with Safety Concerns" list, banning compounding.

Peptides banned in October 2023: BPC-157, TB-500 (Thymosin Beta-4 fragment), CJC-1295, Ipamorelin, MK-677, Thymosin Alpha-1, Epitalon, AOD-9604, GHRP-2, GHRP-6, Semax, Selank, Melanotan II, MOTS-c, GHK-Cu (injectable), Kisspeptin-10, and others.

Reapproved as of March 2026: CJC-1295, Ipamorelin, and Thymosin Alpha-1.

Expected changes: On February 27, 2026, HHS Secretary RFK Jr. announced on Joe Rogan's podcast that approximately 14 of the 19 restricted peptides are expected to return to Category 1 status, which would restore compounding pharmacy access. However, the FDA has not yet published formal updated guidance, so most restricted peptides remain technically banned.

BPC-157 is also prohibited by WADA (World Anti-Doping Agency), relevant for competitive athletes.

Key Takeaways

• Huberman's personal peptide experience is limited to five compounds: BPC-157, Pinealon, Sermorelin, MK-677, and Semax
• BPC-157 resolved his chronic back pain in two injections; Pinealon doubled his REM sleep
• He stopped using Sermorelin due to disrupted REM sleep and elevated PSA
• For growth hormone support, he recommends Ipamorelin at 100 mcg as the cleanest option
• All growth hormone and healing peptides carry theoretical cancer promotion risks through VEGF/GH pathways
• Gray market peptides risk LPS contamination and anaphylaxis
• Regulatory status is in flux; watch for FDA updates following RFK Jr.'s February 2026 announcement
• Work with a physician and licensed compounding pharmacy for any peptide use

Frequently Asked Questions

What peptides does Andrew Huberman personally use?

Huberman has publicly confirmed using BPC-157 (for back pain), Pinealon (for REM sleep), Sermorelin (discontinued due to side effects), MK-677 (single trial only), and Semax (for cognitive focus). He has not used GLP-1 agonists.

Is BPC-157 legal in 2026?

BPC-157 remains on the FDA's Category 2 restricted list as of May 2026, meaning licensed compounding pharmacies cannot legally prepare it. HHS Secretary RFK Jr. announced in February 2026 that it may return to Category 1 status, but this change has not yet been formalized. Pentadeca Arginate (PDA) is the current prescription alternative.

What does Huberman recommend for injury healing?

Huberman's experience favors BPC-157 (or PDA as its current alternative) at 300-500 mcg subcutaneously near the injury site, two to three times weekly for eight weeks. He also discusses TB-500 as a complementary option, though he has not confirmed personal use of TB-500.

Does Huberman recommend GLP-1 medications like Ozempic?

Huberman has discussed GLP-1 agonists extensively but has never used them. He's expressed interest in retatrutide for its apparent muscle-sparing effects and has recommended micro-dosing approaches combined with protein and resistance training to minimize muscle loss.

Where does Huberman say to buy peptides?

Only from board-certified physicians working with licensed compounding pharmacies. He explicitly warns against gray market or "research only" sources due to lipopolysaccharide contamination risks.

Sources

• Benefits & Risks of Peptide Therapeutics for Physical & Mental Health - Huberman Lab
• Dr. Craig Koniver: Peptide & Hormone Therapies - Huberman Lab
• Andrew Huberman's Peptide List - Fast Life Hacks
• BPC-157 FDA Status 2026 - AgeMD
• BPC-157 vs Pentadeca Arginate - American Wellness Pharmacy
• Dr. Zachary Knight: The Science of Hunger - Huberman Lab
• Peptide Therapy in 2026 - Modern Clinician